GTR Home > Tests > Multiple Endocrine Neoplasia Type 2

Overview

Test order codeHelp: 2680

Test name

Help

Multiple Endocrine Neoplasia Type 2

Purpose of the test

Help

This is a clinical test intended for Help: Mutation Confirmation, Diagnosis

Condition

Help

1 condition tested. Click Indication tab for more information.

Methodology

Help
Molecular Genetics
CSequence analysis of the entire coding region
Bi-directional Sanger Sequence Analysis

Summary of what is tested

1 genes and variants. Click Methodology tab for more information.

Genes

Clinical validity

Help

Mutations in the RET gene account for up to 98% of individuals affected with MEN2.

Citations

Not provided

Clinical utility

Help

Not provided

Testing strategy

Help

Test can be run as an individual gene sequence analysis, on the PGLNext panel, or specific site analysis.

How to order

Help

Order URL Help: http://ambrygen.com/forms

Test services

Help
  • Clinical Testing/Confirmation of Mutations Identified Previously, Order code: 2680
  • Clinical Testing/Confirmation of Mutations Identified Previously, Order code: 5504
  • Custom mutation-specific/Carrier testing

Clinical resources

Practice guidelines

  • NSGC, 2004
    Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
  • Brandi et al., 2001
    Guidelines for diagnosis and therapy of MEN type 1 and type 2.

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.